LOTEPREDNOL ETABONATE

LOTEPREDNOL ETABONATE was reported 5433 times

LOTEPREDNOL ETABONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LAMELLAR KERATITIS 9 0.2143
1 CORNEAL FLAP COMPLICATION 3 0.1667
2 GIANT PAPILLARY CONJUNCTIVITIS 7 0.1400
3 CORNEAL STRIAE 8 0.1127
4 INSTILLATION SITE SWELLING 12 0.0686
5 CORNEAL THICKENING 4 0.0588
6 CORNEAL ENDOTHELIAL CELL LOSS 4 0.0588
7 INSTILLATION SITE FOREIGN BODY SENSATION 8 0.0552
8 CORNEAL GRAFT REJECTION 11 0.0524
9 INSTILLATION SITE ERYTHEMA 26 0.0492
10 PERIORBITAL PAIN 41 0.0484
11 INSTILLATION SITE DRYNESS 6 0.0465
12 CHEMICAL EYE INJURY 4 0.0408
13 UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE 4 0.0336
14 EYELID PAIN 66 0.0324
15 CORNEAL SCAR 16 0.0318
16 BLADDER CYST 5 0.0309
17 DIALYSIS HYPOTENSION 3 0.0303
18 CORNEAL DEFECT 4 0.0303
19 INSTILLATION SITE DISCOMFORT 4 0.0299
20 CORNEAL EXFOLIATION 3 0.0294
21 CORNEAL INFILTRATES 9 0.0287
22 EYE INFECTION VIRAL 9 0.0280
23 DEAFNESS PERMANENT 5 0.0255
24 CONTACT LENS INTOLERANCE 4 0.0255
25 INSTILLATION SITE LACRIMATION 6 0.0248
26 CORNEAL DYSTROPHY 10 0.0239
27 CRUSH INJURY 3 0.0234
28 ANTERIOR CHAMBER FIBRIN 3 0.0233
29 CORNEAL INFECTION 5 0.0230
30 INSTILLATION SITE PRURITUS 8 0.0212
31 FOREIGN BODY SENSATION IN EYES 132 0.0207
32 PUNCTATE KERATITIS 18 0.0196
33 GREATER TROCHANTERIC PAIN SYNDROME 4 0.0195
34 CORNEAL THINNING 5 0.0195
35 INSTILLATION SITE IRRITATION 23 0.0194
36 INSTILLATION SITE PAIN 48 0.0194
37 CORNEAL PERFORATION 12 0.0190
38 CORNEAL DEPOSITS 14 0.0188
39 DEPOSIT EYE 5 0.0187
40 CORNEAL DECOMPENSATION 3 0.0186
41 CORNEAL DEGENERATION 4 0.0165
42 CORNEAL ABRASION 22 0.0160
43 REACTION TO PRESERVATIVES 13 0.0160
44 DACRYOSTENOSIS ACQUIRED 20 0.0155
45 CORNEAL OEDEMA 33 0.0147
46 ULCERATIVE KERATITIS 39 0.0142
47 DUODENAL POLYP 3 0.0142
48 CORNEAL TRANSPLANT 11 0.0140
49 EYELID IRRITATION 35 0.0139
50 KERATOCONJUNCTIVITIS SICCA 5 0.0136
51 FOREIGN BODY IN EYE 13 0.0136
52 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
53 EYE PAIN 738 0.0131
54 EYE INFECTION FUNGAL 5 0.0129
55 OCULAR DISCOMFORT 145 0.0129
56 VISUAL ACUITY TESTS ABNORMAL 7 0.0126
57 POSTERIOR CAPSULE OPACIFICATION 4 0.0117
58 CORNEAL DISORDER 25 0.0114
59 CONJUNCTIVITIS VIRAL 3 0.0113
60 SUPERFICIAL INJURY OF EYE 12 0.0110
61 EYE IRRITATION 627 0.0109
62 HYPOPYON 9 0.0109
63 EYE INFECTION BACTERIAL 6 0.0108
64 EYELID MARGIN CRUSTING 30 0.0104
65 CORNEAL EPITHELIUM DEFECT 6 0.0103
66 SCLERAL HYPERAEMIA 7 0.0103
67 INTRAOCULAR PRESSURE INCREASED 126 0.0098
68 CATARACT SUBCAPSULAR 6 0.0098
69 EYE DISCHARGE 100 0.0096
70 CONJUNCTIVITIS ALLERGIC 14 0.0094
71 CORNEAL EROSION 5 0.0093
72 PHOTOPHOBIA 173 0.0092
73 INSTILLATION SITE REACTION 10 0.0092
74 ABNORMAL SENSATION IN EYE 39 0.0091
75 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0088
76 CORNEAL OPACITY 12 0.0088
77 EYE INFLAMMATION 83 0.0087
78 EYE ULCER 5 0.0087
79 INTRAOCULAR PRESSURE TEST ABNORMAL 6 0.0085
80 GASTRIC VARICES 4 0.0085
81 SWELLING OF EYELID 51 0.0081
82 CYSTOID MACULAR OEDEMA 15 0.0080
83 EYE ALLERGY 12 0.0077
84 BLEPHARITIS 31 0.0077
85 PRODUCT DROPPER ISSUE 6 0.0076
86 OCULAR HYPERAEMIA 350 0.0074
87 EYELID RASH 7 0.0072
88 PORTAL HYPERTENSIVE GASTROPATHY 4 0.0071
89 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 4 0.0069
90 EYE BURNS 4 0.0068
91 HYPOAESTHESIA EYE 4 0.0068
92 PRODUCT PHYSICAL CONSISTENCY ISSUE 37 0.0067
93 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
94 PRODUCT DELIVERY MECHANISM ISSUE 35 0.0065
95 HALO VISION 7 0.0062
96 LACRIMATION INCREASED 187 0.0062
97 OCULAR HYPERTENSION 12 0.0062
98 EYELIDS PRURITUS 19 0.0061
99 ASTHENOPIA 33 0.0060
100 HYPERPARATHYROIDISM SECONDARY 15 0.0060
101 GLARE 3 0.0058
102 EPISCLERITIS 4 0.0058
103 ENDOCRINE OPHTHALMOPATHY 5 0.0058
104 ERYTHEMA OF EYELID 31 0.0057
105 TOXIC ANTERIOR SEGMENT SYNDROME 6 0.0055
106 PERIORBITAL SWELLING 30 0.0053
107 HYPERMETROPIA 5 0.0053
108 EYELID EXFOLIATION 4 0.0051
109 EYELID FUNCTION DISORDER 4 0.0051
110 ANTERIOR CHAMBER INFLAMMATION 3 0.0050
111 KERATITIS 15 0.0049
112 IRITIS 15 0.0049
113 EYE COLOUR CHANGE 5 0.0049
114 OCULAR VASCULAR DISORDER 4 0.0048
115 EYE SWELLING 179 0.0048
116 EYE PRURITUS 161 0.0048
117 EYE INFECTION 53 0.0047
118 DRY EYE 229 0.0046
119 PRODUCT DEPOSIT 7 0.0045
120 BONE CONTUSION 4 0.0044
121 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
122 FACIAL DISCOMFORT 3 0.0042
123 PRODUCT CONTAINER ISSUE 36 0.0042
124 COLON ADENOMA 4 0.0041
125 AUTONOMIC NEUROPATHY 4 0.0039
126 PRODUCT CLOSURE REMOVAL DIFFICULT 4 0.0039
127 EYE OPERATION 18 0.0039
128 THYROID HORMONES INCREASED 4 0.0038
129 HERPES OPHTHALMIC 5 0.0038
130 SCLERITIS 6 0.0037
131 NEPHROGENIC ANAEMIA 17 0.0037
132 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
133 EYELID DISORDER 8 0.0035
134 ABDOMINAL LYMPHADENOPATHY 3 0.0035
135 RECTAL ULCER 4 0.0034
136 GLAUCOMA 65 0.0034
137 APRAXIA 5 0.0034
138 EYELID SKIN DRYNESS 4 0.0033
139 CERUMEN IMPACTION 3 0.0033
140 EYE OEDEMA 8 0.0033
141 HORDEOLUM 14 0.0032
142 ENDOPHTHALMITIS 19 0.0032
143 RETINAL DISORDER 8 0.0031
144 MACULAR OEDEMA 17 0.0030
145 VISION BLURRED 400 0.0029
146 TREATMENT DELAYED 5 0.0029
147 BLOOD BLISTER 9 0.0029
148 VITREOUS FLOATERS 28 0.0028
149 IRIDOCYCLITIS 9 0.0028
150 CONJUNCTIVAL HYPERAEMIA 10 0.0028
151 SEBORRHOEIC KERATOSIS 4 0.0028
152 EYELID OEDEMA 32 0.0028
153 ACARODERMATITIS 3 0.0027
154 PRE-EXISTING CONDITION IMPROVED 17 0.0027
155 BODY TEMPERATURE ABNORMAL 5 0.0027
156 EYE INJURY 8 0.0026
157 STOMA SITE HAEMORRHAGE 4 0.0026
158 FOLATE DEFICIENCY 3 0.0026
159 PRODUCT RESIDUE PRESENT 14 0.0026
160 KERATOPATHY 4 0.0025
161 FACIAL BONES FRACTURE 9 0.0025
162 PNEUMONIA LEGIONELLA 4 0.0025
163 CHRONIC SINUSITIS 9 0.0024
164 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
165 EYE DISORDER 78 0.0024
166 HEPATORENAL SYNDROME 4 0.0024
167 EAR SWELLING 5 0.0024
168 PRODUCT ADMINISTRATION ERROR 47 0.0023
169 ACUTE SINUSITIS 4 0.0023
170 REBOUND ACID HYPERSECRETION 7 0.0023
171 VITREOUS DETACHMENT 5 0.0023
172 CONJUNCTIVITIS 42 0.0023
173 CATARACT OPERATION 13 0.0022
174 MENOPAUSAL SYMPTOMS 5 0.0021
175 ECHOCARDIOGRAM ABNORMAL 3 0.0021
176 VISUAL ACUITY REDUCED 71 0.0021
177 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
178 UVEITIS 27 0.0020
179 ASTIGMATISM 3 0.0020
180 PROSTATITIS 6 0.0020
181 EYELID PTOSIS 20 0.0020
182 PRODUCT USE COMPLAINT 31 0.0020
183 DIABETIC FOOT 6 0.0020
184 SPINAL STENOSIS 8 0.0019
185 PRODUCT PRESCRIBING ERROR 45 0.0019
186 CATARACT 110 0.0018
187 DEAFNESS NEUROSENSORY 6 0.0018
188 FEMALE GENITAL TRACT FISTULA 3 0.0018
189 PRODUCT PRESCRIBING ISSUE 38 0.0017
190 ROSACEA 8 0.0017
191 PERIPHERAL VENOUS DISEASE 7 0.0017
192 ESCHERICHIA BACTERAEMIA 4 0.0017
193 INGROWING NAIL 4 0.0017
194 MEDICATION RESIDUE PRESENT 8 0.0017
195 DERMATITIS CONTACT 19 0.0017
196 EAR DISCOMFORT 17 0.0017
197 ESSENTIAL HYPERTENSION 3 0.0016
198 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
199 PIGMENTATION DISORDER 10 0.0016
200 ARTHROPOD BITE 12 0.0016
201 MULTIPLE USE OF SINGLE-USE PRODUCT 9 0.0016
202 BLOOD IRON INCREASED 3 0.0016
203 BLOOD BICARBONATE DECREASED 3 0.0016
204 PHYSICAL DISABILITY 7 0.0016
205 ROTATOR CUFF SYNDROME 20 0.0016
206 PHYSICAL DECONDITIONING 4 0.0016
207 MEDICATION RESIDUE 4 0.0016
208 RETINAL DETACHMENT 14 0.0015
209 NASAL DISCOMFORT 12 0.0015
210 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0015
211 TEMPOROMANDIBULAR JOINT SYNDROME 4 0.0015
212 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
213 FINGER DEFORMITY 7 0.0014
214 CAROTID ARTERY STENOSIS 5 0.0014
215 VISUAL IMPAIRMENT 177 0.0014
216 PROCTITIS 4 0.0014
217 EYE HAEMORRHAGE 19 0.0014
218 AORTIC VALVE INCOMPETENCE 6 0.0014
219 MULTIPLE ALLERGIES 11 0.0014
220 SKIN WEEPING 5 0.0014
221 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
222 BONE LESION 5 0.0014
223 ECONOMIC PROBLEM 21 0.0014
224 SCLERODERMA 5 0.0014
225 PRODUCT COLOUR ISSUE 7 0.0014
226 BLINDNESS UNILATERAL 19 0.0013
227 FACIAL PAIN 12 0.0013
228 SEASONAL ALLERGY 19 0.0013
229 MALABSORPTION 7 0.0013
230 INABILITY TO AFFORD MEDICATION 13 0.0013
231 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
232 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
233 SKIN LACERATION 14 0.0013
234 INFUSION SITE PRURITUS 4 0.0013
235 SINUS DISORDER 25 0.0013
236 BLADDER PAIN 4 0.0013
237 MACULAR DEGENERATION 15 0.0013
238 ORTHOPNOEA 4 0.0013
239 VISUAL FIELD DEFECT 9 0.0012
240 WEIGHT FLUCTUATION 13 0.0012
241 ANTINUCLEAR ANTIBODY POSITIVE 4 0.0012
242 BODY HEIGHT DECREASED 13 0.0012
243 END STAGE RENAL DISEASE 22 0.0012
244 CORONARY ARTERY STENOSIS 6 0.0012
245 KLEBSIELLA INFECTION 6 0.0012
246 EXCORIATION 3 0.0012
247 TOOTH FRACTURE 13 0.0012
248 SINUS HEADACHE 7 0.0012
249 SYMPTOM RECURRENCE 7 0.0012
250 SNEEZING 26 0.0012
251 CHRONIC KIDNEY DISEASE 88 0.0012
252 TACHYPHRENIA 4 0.0012
253 IMPAIRED DRIVING ABILITY 13 0.0011
254 INCORRECT PRODUCT STORAGE 15 0.0011
255 EAR PRURITUS 4 0.0011
256 ONYCHOMYCOSIS 5 0.0011
257 SPINAL OSTEOARTHRITIS 10 0.0011
258 BRONCHIOLITIS 4 0.0011
259 ATRIAL FLUTTER 9 0.0011
260 FOOD POISONING 6 0.0011
261 ABDOMINAL MASS 3 0.0011
262 IMPAIRED QUALITY OF LIFE 16 0.0011
263 SINUS CONGESTION 15 0.0011
264 CHRONIC GRAFT VERSUS HOST DISEASE 4 0.0011
265 BLINDNESS TRANSIENT 8 0.0011
266 PRODUCT LEAKAGE 6 0.0011
267 SKIN TIGHTNESS 5 0.0011
268 PRODUCT AVAILABILITY ISSUE 24 0.0011
269 PSEUDOMONAS INFECTION 9 0.0010
270 SKIN ATROPHY 6 0.0010
271 HYPERTONIC BLADDER 3 0.0010
272 IMMUNOSUPPRESSION 9 0.0010
273 PANCREATIC DISORDER 5 0.0010
274 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
275 VITAMIN B12 DEFICIENCY 4 0.0010
276 DEVICE USE ISSUE 17 0.0010
277 VARICOSE VEIN 5 0.0010
278 INFUSION SITE SWELLING 6 0.0010
279 THERAPY INTERRUPTED 68 0.0010
280 PHOTOPSIA 6 0.0009
281 MADAROSIS 11 0.0009
282 HEPATIC PAIN 4 0.0009
283 PRODUCT DISPENSING ISSUE 4 0.0009
284 DECREASED ACTIVITY 10 0.0009
285 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
286 JAW DISORDER 5 0.0009
287 BURSITIS 11 0.0009
288 CATHETERISATION CARDIAC 4 0.0009
289 PELVIC FRACTURE 7 0.0009
290 GALLBLADDER DISORDER 16 0.0009
291 IRON DEFICIENCY 4 0.0009
292 HEPATIC CYST 3 0.0009
293 RENAL CYST 7 0.0009
294 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
295 EXOSTOSIS 8 0.0009
296 TRANSPLANT REJECTION 7 0.0009
297 EAR DISORDER 4 0.0009
298 RESPIRATION ABNORMAL 6 0.0009
299 CERVICAL VERTEBRAL FRACTURE 3 0.0009
300 LYMPHOEDEMA 6 0.0009
301 FORMICATION 6 0.0009
302 INSURANCE ISSUE 13 0.0008
303 GLOSSITIS 3 0.0008
304 APPENDICECTOMY 3 0.0008
305 SLEEP APNOEA SYNDROME 16 0.0008
306 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
307 WRIST FRACTURE 10 0.0008
308 INFUSION SITE ERYTHEMA 7 0.0008
309 TOOTHACHE 15 0.0008
310 RASH VESICULAR 4 0.0008
311 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
312 BREATH SOUNDS ABNORMAL 4 0.0008
313 PSYCHOLOGICAL TRAUMA 7 0.0008
314 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
315 EXPIRED DRUG ADMINISTERED 4 0.0008
316 BLEPHAROSPASM 5 0.0008
317 MULTIPLE INJURIES 5 0.0008
318 PATHOLOGICAL FRACTURE 4 0.0008
319 PHOTOSENSITIVITY REACTION 13 0.0008
320 DRY THROAT 8 0.0008
321 BLINDNESS 32 0.0008
322 GOUT 14 0.0008
323 MYDRIASIS 10 0.0008
324 FOOD ALLERGY 6 0.0008
325 CONCUSSION 6 0.0008
326 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
327 HIATUS HERNIA 10 0.0008
328 PERIORBITAL OEDEMA 4 0.0008
329 ACCIDENTAL OVERDOSE 28 0.0008
330 INCREASED TENDENCY TO BRUISE 7 0.0008
331 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
332 ERYTHEMA MULTIFORME 7 0.0007
333 PRODUCT USE IN UNAPPROVED INDICATION 186 0.0007
334 BRUXISM 4 0.0007
335 GINGIVITIS 4 0.0007
336 BURNING SENSATION 52 0.0007
337 GALLBLADDER OPERATION 3 0.0007
338 BACK DISORDER 12 0.0007
339 IMMUNODEFICIENCY 11 0.0007
340 PRODUCT LABEL ISSUE 5 0.0007
341 ECCHYMOSIS 5 0.0007
342 ONYCHOCLASIS 5 0.0007
343 LARGE INTESTINE POLYP 5 0.0007
344 FOOT DEFORMITY 8 0.0007
345 PHARYNGEAL SWELLING 7 0.0007
346 EAR INFECTION 19 0.0007
347 RHINORRHOEA 46 0.0007
348 BUNDLE BRANCH BLOCK LEFT 3 0.0007
349 DIVERTICULUM 5 0.0007
350 INTENTIONAL PRODUCT USE ISSUE 61 0.0007
351 HERPES VIRUS INFECTION 4 0.0007
352 CARDIAC MURMUR 6 0.0007
353 PARAESTHESIA ORAL 10 0.0007
354 RHEUMATOID FACTOR POSITIVE 4 0.0007
355 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
356 RALES 4 0.0007
357 TOOTH INFECTION 9 0.0007
358 ABDOMINAL ABSCESS 3 0.0007
359 TINNITUS 31 0.0007
360 BLOOD IRON DECREASED 8 0.0007
361 PULMONARY MASS 10 0.0007
362 IMPAIRED HEALING 22 0.0007
363 EAR PAIN 13 0.0007
364 HEARING IMPAIRED 4 0.0007
365 BLOOD PRESSURE FLUCTUATION 16 0.0007
366 SKIN FISSURES 13 0.0007
367 GANGRENE 4 0.0007
368 PAROSMIA 5 0.0007
369 FULL BLOOD COUNT ABNORMAL 7 0.0007
370 OSTEOARTHRITIS 28 0.0007
371 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
372 RESTLESS LEGS SYNDROME 12 0.0007
373 NEURALGIA 16 0.0007
374 DISABILITY 13 0.0007
375 DIPLOPIA 17 0.0007
376 NERVE COMPRESSION 6 0.0006
377 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
378 OROPHARYNGEAL PAIN 60 0.0006
379 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
380 DERMATITIS ATOPIC 34 0.0006
381 GASTRITIS EROSIVE 3 0.0006
382 THERAPY PARTIAL RESPONDER 10 0.0006
383 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
384 EXPIRED PRODUCT ADMINISTERED 21 0.0006
385 TRICUSPID VALVE INCOMPETENCE 5 0.0006
386 PRODUCT DOSE OMISSION ISSUE 185 0.0006
387 GINGIVAL PAIN 5 0.0006
388 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
389 FAECAL INCONTINENCE 3 0.0006
390 HEAD DISCOMFORT 11 0.0006
391 ATELECTASIS 6 0.0006
392 INFUSION SITE PAIN 8 0.0006
393 DERMATITIS 13 0.0006
394 LOCALISED INFECTION 15 0.0006
395 VITAMIN D DEFICIENCY 6 0.0006
396 POLYURIA 5 0.0006
397 ORAL CANDIDIASIS 8 0.0006
398 PRODUCT QUALITY ISSUE 81 0.0006
399 INTENTIONAL DOSE OMISSION 17 0.0006
400 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
401 SENSATION OF FOREIGN BODY 5 0.0006
402 OSTEOPENIA 9 0.0006
403 LIMB INJURY 16 0.0006
404 DISEASE RECURRENCE 28 0.0006
405 FEMORAL NECK FRACTURE 3 0.0006
406 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
407 JOINT EFFUSION 4 0.0006
408 EXPOSURE VIA SKIN CONTACT 15 0.0006
409 GASTRIC ULCER 11 0.0006
410 SKIN SWELLING 5 0.0006
411 ANHEDONIA 15 0.0006
412 CONDITION AGGRAVATED 173 0.0006
413 RESPIRATORY TRACT CONGESTION 9 0.0006
414 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
415 SCIATICA 9 0.0006
416 RETINAL HAEMORRHAGE 4 0.0006
417 PRODUCT SUPPLY ISSUE 4 0.0006
418 DISCOMFORT 34 0.0006
419 SINUSITIS 57 0.0006
420 GASTROENTERITIS VIRAL 10 0.0006
421 OROPHARYNGEAL DISCOMFORT 5 0.0006
422 BIPOLAR DISORDER 6 0.0006
423 FAECES SOFT 4 0.0005
424 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
425 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 111 0.0005
426 ORAL DISORDER 4 0.0005
427 INFUSION RELATED REACTION 36 0.0005
428 DENTAL CARIES 6 0.0005
429 RENAL FAILURE 72 0.0005
430 IRON DEFICIENCY ANAEMIA 5 0.0005
431 TOOTH DISORDER 12 0.0005
432 THROAT IRRITATION 24 0.0005
433 EPISTAXIS 40 0.0005
434 PRESYNCOPE 13 0.0005
435 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
436 MITRAL VALVE INCOMPETENCE 6 0.0005
437 SPINAL DISORDER 5 0.0005
438 FOOT FRACTURE 10 0.0005
439 BLOOD URINE PRESENT 10 0.0005
440 PRODUCT PACKAGING ISSUE 5 0.0005
441 LIPASE INCREASED 4 0.0005
442 NECK PAIN 29 0.0005
443 CHOLELITHIASIS 17 0.0005
444 HYPERCHOLESTEROLAEMIA 5 0.0005
445 PRODUCT TASTE ABNORMAL 7 0.0005
446 DIZZINESS POSTURAL 5 0.0005
447 VASCULITIS 6 0.0005
448 DYSGEUSIA 38 0.0005
449 OFF LABEL USE 446 0.0005
450 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
451 TREATMENT FAILURE 42 0.0005
452 PRODUCT DOSE OMISSION 33 0.0005
453 FURUNCLE 4 0.0005
454 POLLAKIURIA 21 0.0005
455 CARDIAC PACEMAKER INSERTION 3 0.0005
456 PRODUCTIVE COUGH 24 0.0005
457 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
458 SENSORY DISTURBANCE 8 0.0005
459 DEAFNESS 13 0.0005
460 CORONARY ARTERY DISEASE 15 0.0005
461 NOCTURIA 6 0.0005
462 MUSCLE TIGHTNESS 8 0.0005
463 EXTRA DOSE ADMINISTERED 20 0.0005
464 TREATMENT NONCOMPLIANCE 27 0.0005
465 SWELLING FACE 32 0.0005
466 TOOTH ABSCESS 5 0.0005
467 BLOOD PRESSURE INCREASED 75 0.0005
468 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
469 RIB FRACTURE 10 0.0005
470 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
471 HYPERSENSITIVITY 90 0.0005
472 INFLAMMATION 25 0.0005
473 HEART RATE DECREASED 17 0.0005
474 ARTHRITIS 38 0.0005
475 HAIR COLOUR CHANGES 6 0.0005
476 VENTRICULAR EXTRASYSTOLES 5 0.0005
477 FREQUENT BOWEL MOVEMENTS 13 0.0005
478 TENDERNESS 5 0.0005
479 NASAL CONGESTION 28 0.0005
480 CANDIDA INFECTION 8 0.0005
481 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
482 IRRITABLE BOWEL SYNDROME 10 0.0005
483 CARDIAC OPERATION 4 0.0005
484 MUSCULOSKELETAL DISCOMFORT 8 0.0005
485 SKIN CANCER 10 0.0005
486 ANGINA UNSTABLE 3 0.0005
487 HERPES SIMPLEX 3 0.0005
488 HAEMORRHOIDS 9 0.0005
489 NASOPHARYNGITIS 85 0.0005
490 ORAL HERPES 9 0.0005
491 SURGERY 27 0.0005
492 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
493 KIDNEY INFECTION 9 0.0005
494 HEADACHE 287 0.0005
495 NAIL DISORDER 4 0.0005
496 IMMUNE SYSTEM DISORDER 6 0.0005
497 ANKYLOSING SPONDYLITIS 6 0.0005
498 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
499 GASTROINTESTINAL PAIN 5 0.0005
500 HAEMATOCRIT DECREASED 9 0.0005
501 APPETITE DISORDER 3 0.0005
502 HERPES ZOSTER 26 0.0005
503 ANKLE FRACTURE 7 0.0005
504 HAIR TEXTURE ABNORMAL 6 0.0004
505 GLOSSODYNIA 10 0.0004
506 BRONCHITIS 33 0.0004
507 SKIN INFECTION 5 0.0004
508 BLOOD CALCIUM DECREASED 5 0.0004
509 THROAT TIGHTNESS 12 0.0004
510 TASTE DISORDER 9 0.0004
511 LIP DRY 4 0.0004
512 OPTIC NEURITIS 4 0.0004
513 ABNORMAL LOSS OF WEIGHT 3 0.0004
514 OBESITY 7 0.0004
515 CHOLECYSTECTOMY 5 0.0004
516 HAIR GROWTH ABNORMAL 3 0.0004
517 PROCEDURAL PAIN 12 0.0004
518 ELECTROLYTE IMBALANCE 5 0.0004
519 THERAPEUTIC RESPONSE DECREASED 26 0.0004
520 THERAPY CESSATION 22 0.0004
521 BALANCE DISORDER 37 0.0004
522 LACERATION 4 0.0004
523 COLITIS 16 0.0004
524 VIRAL INFECTION 14 0.0004
525 ECZEMA 22 0.0004
526 RED BLOOD CELL COUNT DECREASED 12 0.0004
527 HYPERLIPIDAEMIA 5 0.0004
528 CELLULITIS 21 0.0004
529 SWELLING 39 0.0004
530 POST PROCEDURAL COMPLICATION 8 0.0004
531 DRUG PRESCRIBING ERROR 8 0.0004
532 PRURITUS GENERALISED 9 0.0004
533 NEPHROLITHIASIS 19 0.0004
534 SINUS BRADYCARDIA 4 0.0004
535 HYPOKINESIA 6 0.0004
536 OSTEOPOROSIS 17 0.0004
537 MENTAL IMPAIRMENT 10 0.0004
538 HEAD INJURY 13 0.0004
539 AUTOIMMUNE DISORDER 4 0.0004
540 PRODUCT USE ISSUE 77 0.0004
541 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
542 SCAR 7 0.0004
543 CYSTITIS 13 0.0004
544 THERAPY CHANGE 4 0.0004
545 TENDON RUPTURE 5 0.0004
546 SKIN EXFOLIATION 34 0.0004
547 BLADDER DISORDER 4 0.0004
548 APPLICATION SITE IRRITATION 5 0.0004
549 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
550 GENERAL SYMPTOM 3 0.0004
551 HYPOAESTHESIA ORAL 6 0.0004
552 DIVERTICULITIS 11 0.0004
553 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
554 DRUG LEVEL DECREASED 4 0.0004
555 DRUG DISPENSING ERROR 6 0.0004
556 SLUGGISHNESS 4 0.0004
557 BOWEL MOVEMENT IRREGULARITY 3 0.0004
558 OXYGEN SATURATION DECREASED 22 0.0004
559 DRUG ADMINISTRATION ERROR 12 0.0004
560 PHARYNGEAL OEDEMA 6 0.0004
561 PAIN IN JAW 11 0.0004
562 MIGRAINE 37 0.0004
563 TENDONITIS 6 0.0004
564 OEDEMA 21 0.0004
565 URINARY TRACT INFECTION 66 0.0004
566 POOR VENOUS ACCESS 4 0.0004
567 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
568 BASAL CELL CARCINOMA 6 0.0004
569 PETECHIAE 4 0.0004
570 ANXIETY 109 0.0004
571 GASTROINTESTINAL INFLAMMATION 3 0.0004
572 AFFECTIVE DISORDER 3 0.0004
573 INSOMNIA 101 0.0004
574 ACUTE KIDNEY INJURY 58 0.0004
575 BLOOD ALBUMIN DECREASED 3 0.0004
576 ARTHROPATHY 21 0.0004
577 ADVERSE REACTION 5 0.0004
578 HEPATIC STEATOSIS 7 0.0004
579 EATING DISORDER 8 0.0004
580 JOINT RANGE OF MOTION DECREASED 5 0.0004
581 FRUSTRATION TOLERANCE DECREASED 3 0.0004
582 ERYTHEMA 76 0.0004
583 PHARYNGITIS STREPTOCOCCAL 4 0.0004
584 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
585 FAECES DISCOLOURED 8 0.0004
586 FEELING JITTERY 7 0.0004
587 PULMONARY THROMBOSIS 4 0.0004
588 HYPERAESTHESIA 3 0.0004
589 BLOOD GLUCOSE FLUCTUATION 4 0.0004
590 ESCHERICHIA INFECTION 3 0.0004
591 HAIR DISORDER 3 0.0004
592 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
593 APPLICATION SITE PAIN 8 0.0004
594 VERTIGO 22 0.0004
595 MALNUTRITION 4 0.0004
596 SLEEP DISORDER 25 0.0004
597 HEART RATE IRREGULAR 8 0.0004
598 LYMPHOPENIA 5 0.0004
599 BACK PAIN 82 0.0004
600 SCAB 4 0.0004
601 SKIN ULCER 9 0.0003
602 RASH 151 0.0003
603 HYSTERECTOMY 3 0.0003
604 ANOSMIA 5 0.0003
605 DYSPNOEA EXERTIONAL 13 0.0003
606 HYPERTENSION 73 0.0003
607 ORTHOSTATIC HYPOTENSION 6 0.0003
608 RASH MACULAR 12 0.0003
609 JOINT STIFFNESS 9 0.0003
610 DYSSTASIA 10 0.0003
611 GROIN PAIN 3 0.0003
612 INJURY 24 0.0003
613 NIGHT SWEATS 11 0.0003
614 SPINAL PAIN 4 0.0003
615 ALOPECIA 67 0.0003
616 DIABETES MELLITUS 26 0.0003
617 PRURITUS 131 0.0003
618 GRIP STRENGTH DECREASED 3 0.0003
619 LYMPHADENOPATHY 12 0.0003
620 EMOTIONAL DISTRESS 41 0.0003
621 RENAL INJURY 10 0.0003
622 ACCIDENT 4 0.0003
623 GASTROINTESTINAL INFECTION 3 0.0003
624 PAIN 205 0.0003
625 ANAL INCONTINENCE 3 0.0003
626 STAPHYLOCOCCAL INFECTION 11 0.0003
627 HEART RATE INCREASED 33 0.0003
628 KNEE ARTHROPLASTY 7 0.0003
629 MOUTH ULCERATION 7 0.0003
630 CHEST DISCOMFORT 34 0.0003
631 LIP SWELLING 11 0.0003
632 FATIGUE 257 0.0003
633 ILLNESS 34 0.0003
634 SKIN DISORDER 11 0.0003
635 BLOOD COUNT ABNORMAL 5 0.0003
636 ILL-DEFINED DISORDER 20 0.0003
637 DRUG INEFFECTIVE 431 0.0003
638 DIZZINESS 163 0.0003
639 SKIN DISCOLOURATION 15 0.0003
640 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
641 ABDOMINAL DISTENSION 34 0.0003
642 DYSPEPSIA 32 0.0003
643 CARDIOMEGALY 4 0.0003
644 SPINAL OPERATION 4 0.0003
645 HAEMOPTYSIS 9 0.0003
646 PHARYNGITIS 4 0.0003
647 CYST 4 0.0003
648 CONTUSION 31 0.0003
649 DELUSION 5 0.0003
650 PANCREATITIS 17 0.0003
651 PRODUCT DISPENSING ERROR 7 0.0003
652 MIDDLE INSOMNIA 6 0.0003
653 HYPOAESTHESIA 48 0.0003
654 FLANK PAIN 3 0.0003
655 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
656 PRODUCT STORAGE ERROR 28 0.0003
657 SECRETION DISCHARGE 4 0.0003
658 HEPATIC CIRRHOSIS 6 0.0003
659 COVID-19 56 0.0003
660 WEIGHT DECREASED 89 0.0003
661 DEPRESSION 72 0.0003
662 PROTEINURIA 6 0.0003
663 FALL 105 0.0003
664 MUSCULOSKELETAL DISORDER 6 0.0003
665 FLUID RETENTION 16 0.0003
666 ULCER 5 0.0003
667 COUGH 88 0.0003
668 HYPOPHAGIA 8 0.0003
669 RASH PAPULAR 7 0.0003
670 CARDIAC DISORDER 29 0.0003
671 INTENTIONAL PRODUCT MISUSE 27 0.0003
672 DRY MOUTH 25 0.0003
673 ATRIAL FIBRILLATION 30 0.0003
674 CHEST PAIN 57 0.0003
675 HEPATOMEGALY 3 0.0003
676 PARAESTHESIA 48 0.0003
677 LABORATORY TEST ABNORMAL 9 0.0003
678 GASTRITIS 8 0.0003
679 INFECTION 44 0.0003
680 SARS-COV-2 TEST POSITIVE 4 0.0003
681 PERICARDIAL EFFUSION 7 0.0003
682 HYPOACUSIS 13 0.0003
683 UPPER LIMB FRACTURE 6 0.0003
684 BLOOD PRESSURE DECREASED 20 0.0003
685 FLATULENCE 17 0.0003
686 DRY SKIN 40 0.0003
687 SPINAL FRACTURE 6 0.0003
688 BLOOD POTASSIUM DECREASED 9 0.0003
689 GAIT INABILITY 10 0.0003
690 MALIGNANT MELANOMA 4 0.0003
691 JOINT SWELLING 36 0.0003
692 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
693 MUSCLE SPASMS 54 0.0003
694 BODY TEMPERATURE INCREASED 6 0.0003
695 CORONARY ARTERY OCCLUSION 4 0.0003
696 MEMORY IMPAIRMENT 40 0.0003
697 ACCIDENTAL EXPOSURE TO PRODUCT 30 0.0003
698 GASTROINTESTINAL DISORDER 26 0.0003
699 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
700 FEELING COLD 8 0.0003
701 NERVOUSNESS 15 0.0003
702 INFLUENZA 32 0.0003
703 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
704 URTICARIA 48 0.0003
705 MASS 4 0.0003
706 DRUG DOSE OMISSION 47 0.0003
707 HYPOXIA 10 0.0003
708 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
709 PALPITATIONS 33 0.0003
710 RETCHING 6 0.0003
711 AGEUSIA 7 0.0003
712 BRONCHOSPASM 4 0.0003
713 DRUG EFFECT DECREASED 15 0.0003
714 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
715 CRYING 10 0.0003
716 FLUID OVERLOAD 4 0.0003
717 BONE DISORDER 5 0.0003
718 GASTROENTERITIS 4 0.0003
719 MUSCULOSKELETAL STIFFNESS 24 0.0003
720 DYSPHAGIA 26 0.0003
721 DYSPNOEA 154 0.0003
722 OEDEMA PERIPHERAL 33 0.0003
723 CONSTIPATION 59 0.0003
724 FUNGAL INFECTION 9 0.0003
725 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
726 BACTERIAL INFECTION 5 0.0003
727 ORAL PAIN 6 0.0003
728 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
729 MUSCULOSKELETAL PAIN 14 0.0003
730 THERAPY NON-RESPONDER 12 0.0003
731 ARTHRALGIA 111 0.0003
732 CHROMATURIA 6 0.0003
733 DYSARTHRIA 10 0.0003
734 UNEVALUABLE EVENT 20 0.0003
735 FEELING ABNORMAL 63 0.0003
736 NEUROPATHY PERIPHERAL 25 0.0003
737 ABDOMINAL DISCOMFORT 44 0.0003
738 ABDOMINAL PAIN UPPER 54 0.0003
739 GASTRIC DISORDER 9 0.0003
740 NAUSEA 207 0.0003
741 CARDIAC FAILURE CONGESTIVE 21 0.0003
742 GASTRIC HAEMORRHAGE 3 0.0003
743 PRODUCT SUBSTITUTION ISSUE 15 0.0003
744 PNEUMONIA 84 0.0003
745 PAIN IN EXTREMITY 76 0.0003
746 LUNG INFECTION 4 0.0003
747 ASTHMA 29 0.0003
748 SWOLLEN TONGUE 8 0.0003
749 BONE PAIN 15 0.0003
750 CHILLS 30 0.0003
751 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
752 BLOOD PRESSURE ABNORMAL 5 0.0003
753 RASH ERYTHEMATOUS 12 0.0003
754 PRESCRIBED UNDERDOSE 5 0.0003
755 ASTHENIA 94 0.0002
756 DECREASED APPETITE 58 0.0002
757 HIP FRACTURE 8 0.0002
758 THROMBOSIS 20 0.0002
759 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
760 TACHYCARDIA 22 0.0002
761 DEHYDRATION 33 0.0002
762 MYALGIA 42 0.0002
763 PANIC ATTACK 9 0.0002
764 FIBROMYALGIA 6 0.0002
765 FEEDING DISORDER 5 0.0002
766 FLUSHING 25 0.0002
767 ANGINA PECTORIS 7 0.0002
768 HYPERSOMNIA 7 0.0002
769 MULTIPLE FRACTURES 4 0.0002
770 MANIA 4 0.0002
771 HYPERCALCAEMIA 3 0.0002
772 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
773 TOOTH LOSS 5 0.0002
774 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
775 PERIPHERAL SWELLING 37 0.0002
776 COAGULOPATHY 4 0.0002
777 URINARY RETENTION 8 0.0002
778 NEOPLASM MALIGNANT 16 0.0002
779 DYSPHONIA 14 0.0002
780 BLOOD UREA INCREASED 4 0.0002
781 HALLUCINATION 18 0.0002
782 ACUTE MYOCARDIAL INFARCTION 7 0.0002
783 HALLUCINATION, VISUAL 5 0.0002
784 BLOOD CHOLESTEROL INCREASED 11 0.0002
785 ANAEMIA 45 0.0002
786 MALAISE 103 0.0002
787 HOSPITALISATION 36 0.0002
788 JOINT INJURY 5 0.0002
789 DIARRHOEA 151 0.0002
790 IMPAIRED WORK ABILITY 5 0.0002
791 SOMNOLENCE 47 0.0002
792 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
793 POOR QUALITY SLEEP 5 0.0002
794 WEIGHT INCREASED 52 0.0002
795 RESPIRATORY TRACT INFECTION 6 0.0002
796 APPLICATION SITE ERYTHEMA 6 0.0002
797 EMOTIONAL DISORDER 7 0.0002
798 LYMPHOCYTE COUNT DECREASED 4 0.0002
799 HOT FLUSH 17 0.0002
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
801 GAIT DISTURBANCE 43 0.0002
802 SEPSIS 25 0.0002
803 COLITIS ULCERATIVE 10 0.0002
804 FEAR 6 0.0002
805 LEUKOCYTOSIS 4 0.0002
806 OSTEOMYELITIS 4 0.0002
807 PNEUMONITIS 6 0.0002
808 DRUG EFFECT INCOMPLETE 8 0.0002
809 RHEUMATOID ARTHRITIS 25 0.0002
810 C-REACTIVE PROTEIN INCREASED 8 0.0002
811 HYPOTHYROIDISM 7 0.0002
812 SKIN LESION 6 0.0002
813 SKIN IRRITATION 10 0.0002
814 MOVEMENT DISORDER 7 0.0002
815 NO ADVERSE EVENT 39 0.0002
816 ROAD TRAFFIC ACCIDENT 9 0.0002
817 APHONIA 3 0.0002
818 DEMENTIA 6 0.0002
819 BLOOD CREATININE INCREASED 14 0.0002
820 DEVICE OCCLUSION 3 0.0002
821 BLOOD SODIUM DECREASED 4 0.0002
822 FEELING HOT 13 0.0002
823 FRACTURE 4 0.0002
824 RECTAL HAEMORRHAGE 9 0.0002
825 PULMONARY FIBROSIS 4 0.0002
826 LOWER LIMB FRACTURE 4 0.0002
827 ACUTE RESPIRATORY FAILURE 4 0.0002
828 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
829 ANGER 7 0.0002
830 HERNIA 4 0.0002
831 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
832 RASH PRURITIC 11 0.0002
833 URINARY INCONTINENCE 6 0.0002
834 WHEEZING 12 0.0002
835 RENAL IMPAIRMENT 17 0.0002
836 ABDOMINAL PAIN 47 0.0002
837 COLON CANCER 3 0.0002
838 HAEMORRHAGE INTRACRANIAL 3 0.0002
839 PULMONARY EMBOLISM 19 0.0002
840 PREGNANCY 4 0.0002
841 BONE LOSS 3 0.0002
842 APHASIA 6 0.0002
843 PRODUCT PHYSICAL ISSUE 4 0.0002
844 PRODUCT COMPLAINT 5 0.0002
845 HAEMATEMESIS 5 0.0002
846 HIP ARTHROPLASTY 3 0.0002
847 HAEMOGLOBIN DECREASED 20 0.0002
848 MUSCULAR WEAKNESS 22 0.0002
849 RASH GENERALISED 5 0.0002
850 EJECTION FRACTION DECREASED 3 0.0002
851 HAEMATOMA 5 0.0002
852 TREMOR 32 0.0002
853 COGNITIVE DISORDER 9 0.0002
854 ACUTE MYELOID LEUKAEMIA 3 0.0002
855 BLOOD GLUCOSE INCREASED 36 0.0002
856 SPEECH DISORDER 10 0.0002
857 DYSURIA 7 0.0002
858 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
859 DEPRESSED MOOD 10 0.0002
860 RENAL FAILURE ACUTE 8 0.0002
861 LIVER FUNCTION TEST INCREASED 4 0.0002
862 HYPERHIDROSIS 24 0.0002
863 CONFUSIONAL STATE 30 0.0002
864 HYPOGLYCAEMIA 9 0.0002
865 PYREXIA 64 0.0002
866 HYPOTENSION 37 0.0002
867 MENTAL DISORDER 8 0.0002
868 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
869 STOMATITIS 11 0.0002
870 ANAPHYLACTIC REACTION 10 0.0002
871 SYNCOPE 18 0.0002
872 INCORRECT DOSE ADMINISTERED 41 0.0002
873 WOUND 5 0.0002
874 PULMONARY OEDEMA 8 0.0002
875 FACE OEDEMA 3 0.0002
876 HEMIPARESIS 3 0.0002
877 DISORIENTATION 7 0.0002
878 VOMITING 83 0.0002
879 INJECTION SITE BRUISING 14 0.0002
880 LETHARGY 10 0.0002
881 INJECTION SITE PAIN 53 0.0002
882 HAEMORRHAGE 18 0.0002
883 NEEDLE ISSUE 5 0.0002
884 RENAL DISORDER 8 0.0002
885 HYPERKALAEMIA 6 0.0002
886 COLD SWEAT 3 0.0002
887 ASCITES 5 0.0002
888 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
889 DRUG ERUPTION 3 0.0002
890 DEEP VEIN THROMBOSIS 11 0.0002
891 ARRHYTHMIA 8 0.0002
892 CEREBRAL HAEMORRHAGE 6 0.0002
893 SKIN BURNING SENSATION 12 0.0002
894 ADVERSE DRUG REACTION 15 0.0002
895 DISTURBANCE IN ATTENTION 9 0.0002
896 PLEURAL EFFUSION 10 0.0002
897 RESTLESSNESS 6 0.0002
898 LOSS OF CONSCIOUSNESS 21 0.0002
899 LUNG DISORDER 8 0.0002
900 HAEMATOCHEZIA 9 0.0002
901 FEMUR FRACTURE 5 0.0002
902 INJECTION SITE ERYTHEMA 20 0.0002
903 BLISTER 9 0.0002
904 BONE DENSITY DECREASED 5 0.0002
905 PLATELET COUNT DECREASED 17 0.0002
906 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
907 ABDOMINAL PAIN LOWER 4 0.0002
908 INFLUENZA LIKE ILLNESS 13 0.0002
909 INJECTION SITE SWELLING 12 0.0002
910 ANAPHYLACTIC SHOCK 4 0.0002
911 AMNESIA 10 0.0002
912 PSORIASIS 20 0.0002
913 PSORIATIC ARTHROPATHY 6 0.0001
914 BONE MARROW FAILURE 3 0.0001
915 HEPATIC ENZYME INCREASED 10 0.0001
916 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
917 BLOOD GLUCOSE DECREASED 7 0.0001
918 ABNORMAL DREAMS 4 0.0001
919 DELIRIUM 5 0.0001
920 DISEASE PROGRESSION 17 0.0001
921 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
922 CARDIO-RESPIRATORY ARREST 6 0.0001
923 WITHDRAWAL SYNDROME 6 0.0001
924 HYPONATRAEMIA 8 0.0001
925 SUICIDAL IDEATION 13 0.0001
926 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
927 INJECTION SITE HAEMORRHAGE 11 0.0001
928 HYPERGLYCAEMIA 5 0.0001
929 CARDIAC FAILURE 11 0.0001
930 APPLICATION SITE PRURITUS 3 0.0001
931 BRADYCARDIA 7 0.0001
932 MYOCARDIAL INFARCTION 23 0.0001
933 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
934 ADVERSE EVENT 12 0.0001
935 CEREBROVASCULAR ACCIDENT 22 0.0001
936 SEIZURE 15 0.0001
937 LIMB DISCOMFORT 4 0.0001
938 NERVOUS SYSTEM DISORDER 4 0.0001
939 DRUG INTERACTION 20 0.0001
940 MOOD SWINGS 4 0.0001
941 DRUG INTOLERANCE 12 0.0001
942 NEUTROPHIL COUNT DECREASED 5 0.0001
943 ENCEPHALOPATHY 3 0.0001
944 LUNG NEOPLASM MALIGNANT 5 0.0001
945 EXTRAPYRAMIDAL DISORDER 3 0.0001
946 TYPE 2 DIABETES MELLITUS 4 0.0001
947 GASTRIC CANCER 3 0.0001
948 INJECTION SITE REACTION 8 0.0001
949 SUICIDE ATTEMPT 7 0.0001
950 LIVER DISORDER 5 0.0001
951 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
952 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
953 CARDIAC ARREST 9 0.0001
954 INJECTION SITE MASS 4 0.0001
955 INTESTINAL OBSTRUCTION 4 0.0001
956 CONVULSION 6 0.0001
957 INTERSTITIAL LUNG DISEASE 5 0.0001
958 AGGRESSION 5 0.0001
959 IRRITABILITY 6 0.0001
960 DYSKINESIA 4 0.0001
961 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
962 GYNAECOMASTIA 3 0.0001
963 UNDERDOSE 7 0.0001
964 AGITATION 7 0.0001
965 ACNE 7 0.0001
966 DEATH 78 0.0001
967 MEDICATION ERROR 5 0.0001
968 INJECTION SITE PRURITUS 6 0.0001
969 DEVICE ISSUE 8 0.0001
970 HAEMATURIA 3 0.0001
971 HYPOKALAEMIA 4 0.0001
972 DEVICE MALFUNCTION 6 0.0001
973 COMA 4 0.0001
974 RESPIRATORY FAILURE 6 0.0001
975 NEUTROPENIA 11 0.0001
976 ABORTION SPONTANEOUS 3 0.0001
977 MOBILITY DECREASED 5 0.0001
978 DEVICE LEAKAGE 3 0.0001
979 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
980 EXPOSURE DURING PREGNANCY 4 0.0001
981 OVERDOSE 13 0.0001
982 TOXICITY TO VARIOUS AGENTS 10 0.0001
983 BREAST CANCER 5 0.0001
984 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
985 DEVICE EXPULSION 3 0.0000
986 DEVICE DIFFICULT TO USE 3 0.0000
987 FEBRILE NEUTROPENIA 3 0.0000
988 DRUG DEPENDENCE 7 0.0000
989 THROMBOCYTOPENIA 4 0.0000
990 DRUG WITHDRAWAL SYNDROME 3 0.0000